Levocloperastine PCD Pharma Franchise Company

Cafoli Lifecare is a trusted Levocloperastine PCD pharma franchise company offering 2 syrup formulations. Manufactured at WHO-GMP certified facilities, this range gives franchise partners a modern non-opioid antitussive for the large, year-round dry-cough market.

What is Levocloperastine?

Levocloperastine is a non-opioid antitussive (cough suppressant) that acts both centrally and peripherally. Centrally it modulates the cough centre in the medulla, while peripherally it exerts a direct antispasmodic and mild antihistaminic effect on the airways. This dual action suppresses the cough reflex without the sedation or dependence associated with opioid cough suppressants. Learn more on PubChem.

Therapeutic Applications of Levocloperastine

Levocloperastine is used for the symptomatic relief of dry, non-productive and irritating cough of various causes, including cough associated with upper-respiratory infections and allergic irritation. It is prescribed by general physicians, paediatricians, chest physicians and ENT specialists.

Why Levocloperastine is a High-Potential Molecule for Distributors

Dry cough is one of the most common presenting complaints across all seasons in India, sustaining a very large cough-preparation market. Levocloperastine’s non-opioid, low-sedation profile makes it a preferred modern antitussive that avoids the regulatory and safety concerns of codeine-based syrups, giving distributors a fast-moving, compliance-friendly OTC-adjacent molecule with steady demand.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers exclusive district-wise monopoly rights, WHO-GMP certified and DCGI-approved formulations, attractive promotional inputs and marketing support, and the reliability of a network trusted by 1000+ franchise partners across India.

References

1. PubChem – Cloperastine Compound Summary, U.S. National Library of Medicine
2. PubMed – Clinical literature on Cloperastine / Levocloperastine